MedTrace Logo

Surgical Management of Giant Hepatic Hemangioma

NCT04709718 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2021-01-14

No results posted yet for this study

Summary

Hepatic hemangiomas are the commonest benign mesenchymal lesions of the liver. Most of these lesions are asymptomatic. Giant hepatic hemangiomas (GHH) (\> 10 cm) are often symptomatic and require surgical intervention. This study aimed to describe the clinical findings, risk factors, diagnostic approach and management of GHH.

Conditions

  • Liver Angioma

Interventions

PROCEDURE

hepatectomy

liver resection taking over the liver hemangioma

Sponsors & Collaborators

  • Sahloul Hospital of Sousse

    collaborator OTHER

  • Université de Sousse

    lead OTHER

Principal Investigators

  • waad farhat, doctor · university of sousse

Eligibility

Min Age
15 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-01
Primary Completion
2019-06-29
Completion
2020-01-02

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04709718 on ClinicalTrials.gov